Clinical Trials Browser

Phase 2 × Unknown × Lymphoma, T-Cell × Clear all

NCT05367856 2022-09-29

Efficacy and Safety of Chidamide Combined With BEAM Pretreatment Regimen in Autologous Transplantation for T-cell Lymphoma

Phase 2 Unknown

Lymphoma, T-Cell

NCT05059912 2021-09-28

CD7 CAR T-cell for R/R CD7+ T Cell Lymphoma

Phase 2 Unknown

Lymphoma, T-Cell

NCT02533700 2020-03-10

CEOP/IVE/GDP Compared With CEOP as the First-line Therapy for Newly Diagnosed Adult Patients With PTCL

Phase 2 Unknown

DermatologicLymphoid

Subcutaneous panniculitis-like T-cell lymphoma, Immunoblastic Lymphadenopathy, Lymphoma, T-Cell, Enteropathy-Associated T-Cell Lymphoma

NCT03021057 2019-04-17

Pembrolizumab for T/NK-cell lymphomasNK-cell Lymphomas

Phase 2 Unknown

Lymphoma, T-Cell

NCT01719835 2018-03-15

CHEMO-T

Phase 2 Unknown

Immunoblastic Lymphadenopathy, Lymphoma, T-Cell, Lymphoma, Large-Cell, Anaplastic, Enteropathy-Associated T-Cell Lymphoma

NCT01430013 2015-11-04

Trial of Endostar Combined With CHOPT for T Cell Lymphoma

Phase 2 Unknown

Lymphoma, T-Cell

NCT00840385 2010-09-15

FAD

Phase 2 Unknown

Lymphoma, T-Cell, Lymphoma, T-Cell, Peripheral

NCT00974324 2010-09-15

PTCL

Phase 2 Unknown

Lymphoma, T-Cell, Lymphoma, T-Cell, Peripheral